Interferon response of the cystic fibrosis bronchial epithelium to major and minor group rhinovirus infection  Aline Schögler, Andrea B. Stokes, Carmen.

Slides:



Advertisements
Similar presentations
Comparing age of cystic fibrosis diagnosis and treatment initiation after newborn screening with two common strategies  Don B. Sanders, Huichuan J. Lai,
Advertisements

Cheryl Cameron, Mark W. Lodes, William M. Gershan 
Azithromycin fails to reduce increased expression of neutrophil-related cytokines in primary-cultured epithelial cells from cystic fibrosis mice  Ximena.
Interferon (IFN)-Induced Protein 35 (IFI35), a Type I Interferon-Dependent Transcript, Upregulates Inflammatory Signaling Pathways by Activating Toll-Like.
Fig. 4. PVSRIPO infection of DCs is sublethal, is marginally productive, and induces sustained proinflammatory cytokine production. PVSRIPO infection of.
Vitamin D receptor agonists inhibit pro-inflammatory cytokine production from the respiratory epithelium in cystic fibrosis  P. McNally, C. Coughlan,
Is infection with hypermutable Pseudomonas aeruginosa clinically significant?  Adi Auerbach, Eitan Kerem, Marc Victor Assous, Elie Picard, Maskit Bar-Meir 
Development, validation, and implementation of a questionnaire assessing disease knowledge and understanding in adult cystic fibrosis patients  Karen.
Effect of Aspergillus fumigatus and Candida albicans on pro-inflammatory response in cystic fibrosis epithelium  James A. Reihill, John E. Moore, J. Stuart.
Zachary M. Sellers, Lori McGlocklin, Andrea Brasch 
William G. Flight, Jonathan Shaw, Susan Johnson, A
K. L. Nash, M. E. Allison, D. McKeon, D. J. Lomas, C. S. Haworth, D
Abaigeal D. Jackson, Christopher H. Goss  Journal of Cystic Fibrosis 
How does heart rate recovery after sub-maximal exercise correlate with maximal exercise testing in children with CF?  Sarah P. Cohen, David M. Orenstein 
Megan R. Nelson, Craig R. Adamski, Audrey Tluczek 
Simon Haas, Andreas Trumpp  Developmental Cell 
Urinary incontinence in 9���16��year olds with cystic fibrosis compared to other respiratory conditions and a normal group  W.J. Browne, C.J. Wood, M.
Measures of body habitus are associated with lung function in adults with cystic fibrosis: A population-based study  Doug L. Forrester, Alan J. Knox,
Microbiological yield from induced sputum compared to oropharyngeal swab in young children with cystic fibrosis  Marco Zampoli, Komala Pillay, Henri Carrara,
Laura Viviani, Baroukh M. Assael, Eitan Kerem 
Raphaël Chiron, Y. Yaël Grumbach, Nga V. T
Cirrhosis and other liver disease in cystic fibrosis
The ease of breathing test tracks clinical changes in cystic fibrosis
Delayed publication of clinical trials in cystic fibrosis
Expression of the inflammatory regulator A20 correlates with lung function in patients with cystic fibrosis  Catriona Kelly, Mark T. Williams, J. Stuart.
Cynthia M. Ward, Tara Brinkman, Keith J. Slifer, Shruti M. Paranjape 
Anju Anand, Elizabeth Tullis, Anne Stephenson, Preyanka Abhyankar 
D. Stevens, P.J. Oades, N. Armstrong, C.A. Williams 
Claire J. Tipping, Rebecca L. Scholes, Narelle S. Cox 
Antiviral responses of human Fallopian tube epithelial cells to toll-like receptor 3 agonist poly(I:C)  Mimi Ghosh, Ph.D., Todd M. Schaefer, Ph.D., John.
Early inflammation in the airways of a cystic fibrosis foetus
Implementation of European standards of care for cystic fibrosis ��� Control and treatment of infection  J.S. Elborn, M. Hodson, C. Bertram  Journal of.
Vitamin A and lung function in CF
Prenatal diagnosis for CF using High Resolution Melting Analysis and simultaneous haplotype analysis through QF-PCR  Myrto Poulou, Aspasia Destouni, Georgia.
Increased nuclear suppressor of cytokine signaling 1 in asthmatic bronchial epithelium suppresses rhinovirus induction of innate interferons  Vera Gielen,
A.H. Gifford  Journal of Cystic Fibrosis 
Osteoclast function, bone turnover and inflammatory cytokines during infective exacerbations of cystic fibrosis  Elizabeth F. Shead, Charles S. Haworth,
Economic effects of an eradication protocol for first appearance of Pseudomonas aeruginosa in cystic fibrosis patients: 1995 vs. 2009  Yolanda P. Lillquist,
Inhalation solutions — Which ones may be mixed
Physiologic endpoints for clinical studies for cystic fibrosis
Antonia V. Bennett, Donald L. Patrick, James F. Lymp, Todd C
Exogenous IFN-β has antiviral and anti-inflammatory properties in primary bronchial epithelial cells from asthmatic subjects exposed to rhinovirus  Julie.
E. Tschiedel, H. Grasemann, F. Ratjen  Journal of Cystic Fibrosis 
Sally H. Pattison, Geraint B. Rogers, Martin Crockard, J
Anastasios Lekkas, Khin M. Gyi, Margaret E. Hodson 
Cytokine gene polymorphisms and severity of CF lung disease
Nasal polyposis in lung transplant recipients with cystic fibrosis
Novel concepts in evaluating antimicrobial therapy for bacterial lung infections in patients with cystic fibrosis  Geraint B. Rogers, Lucas R. Hoffman,
Australian epidemic strain pseudomonas (AES-1) declines further in a cohort segregated cystic fibrosis clinic  Amanda L. Griffiths, Danielle F. Wurzel,
Nutritional decline in cystic fibrosis related diabetes: The effect of intensive nutritional intervention  H. White, K. Pollard, C. Etherington, I. Clifton,
Gender differences in treatment adherence among youth with cystic fibrosis: Development of a new questionnaire  Joän M. Patterson, Melanie Wall, Jerica.
Michael D. Parkins, R. Andres Floto  Journal of Cystic Fibrosis 
Disease disclosure in individuals with cystic fibrosis: Association with psychosocial and health outcomes  Adrienne P. Borschuk, Robin S. Everhart, Michelle.
Trends in pathogens colonising the respiratory tract of adult patients with cystic fibrosis, 1985–2005  F.A. Millar, N.J. Simmonds, M.E. Hodson  Journal.
Determining presence of lung disease in young children with cystic fibrosis: Lung clearance index, oxygen saturation and cough frequency  E.M. Bakker,
Comparing age of cystic fibrosis diagnosis and treatment initiation after newborn screening with two common strategies  Don B. Sanders, Huichuan J. Lai,
J.E. Spahr, R.B. Love, M. Francois, K. Radford, K.C. Meyer 
Daniel J. Smith, Gregory J. Anderson, Scott C. Bell, David W. Reid 
Decreased interleukin-18 expression in BAL cells and peripheral blood mononuclear cells in adult cystic fibrosis patients  Hans-Peter Hauber, Inga S Beyer,
C. R. Hansen, T. Pressler, K. G. Nielsen, P. Ø. Jensen, T
CFTR modulators and pregnancy: Our work has only just begun
‘Peeling paint’ dermatitis as a presenting sign of cystic fibrosis
L. Nshimyumukiza, A. Bois, P. Daigneault, L. Lands, A. -M. Laberge, D
Beta-lactam allergy in adults with cystic fibrosis
Cheryl Cameron, Mark W. Lodes, William M. Gershan 
Fig. 4. PVSRIPO infection of DCs is sublethal, is marginally productive, and induces sustained proinflammatory cytokine production. PVSRIPO infection of.
Lutz Goldbeck, Sven Zerrer, Tim G. Schmitz  Journal of Cystic Fibrosis 
Khin M. Gyi, Margaret E. Hodson, Magdi Y. Yacoub 
Increasing resistance of the Liverpool Epidemic Strain (LES) of Pseudomonas aeruginosa (Psa) to antibiotics in cystic fibrosis (CF)—A cause for concern? 
Elisabeth P. Dellon, Margaret W. Leigh, James R. Yankaskas, Terry L
Presentation transcript:

Interferon response of the cystic fibrosis bronchial epithelium to major and minor group rhinovirus infection  Aline Schögler, Andrea B. Stokes, Carmen Casaulta, Nicolas Regamey, Michael R. Edwards, Sebastian L. Johnston, Andreas Jung, Alexander Moeller, Thomas Geiser, Marco P. Alves  Journal of Cystic Fibrosis  Volume 15, Issue 3, Pages 332-339 (May 2016) DOI: 10.1016/j.jcf.2015.10.013 Copyright © 2015 European Cystic Fibrosis Society Terms and Conditions

Fig. 1 IFN responses of CF and control BECs to RV infection. (A) IFN-λ1, (B) IFN-λ2/3 and (C) IFN-β mRNA levels measured 24h post-infection by RT-PCR in CF and control BECs. IM (infection media), pIC (poly(IC)). The mRNA levels are represented as relative fold increase to mock infection (IM). Significant differences between conditions (IM, RV16, RV1B, pIC) are indicated by stars above error bars and are relative to the mock infection controls (IM). Significant differences between groups (control and CF) are indicated by horizontal lines. Stars indicate significance levels, *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001. Journal of Cystic Fibrosis 2016 15, 332-339DOI: (10.1016/j.jcf.2015.10.013) Copyright © 2015 European Cystic Fibrosis Society Terms and Conditions

Fig. 2 PRRs expression in CF and control BECs upon RV infection. (A) TLR3, (B) RIG-I and (C) MDA5 mRNA levels measured in cell lysates of primary CF and control BECs 24h post-infection. IM (infection media), pIC (poly(IC)). The mRNA levels are represented as relative fold increase to mock infection (IM). Significant differences between conditions (IM, RV16, RV1B, pIC) are indicated by stars above error bars and are relative to the mock infection controls (IM). Significant differences between groups (control and CF) are indicated by horizontal lines. Stars indicate significance levels, *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001. Journal of Cystic Fibrosis 2016 15, 332-339DOI: (10.1016/j.jcf.2015.10.013) Copyright © 2015 European Cystic Fibrosis Society Terms and Conditions

Fig. 3 ISGs levels upon RV infection of CF and control BECs. (A) PKR, (B) OAS1, (C) viperin and (D) MxA mRNA levels measured in cell lysates of primary CF and control BECs 24h post-infection. IM (infection media), pIC (poly(IC)). The mRNA levels are represented as relative fold increase to mock infection (IM). Significant differences between conditions (IM, RV16, RV1B, pIC) are indicated by stars above error bars and are relative to the mock infection controls (IM). Significant differences between groups (control and CF) are indicated by horizontal lines. Stars indicate significance levels, *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001. Journal of Cystic Fibrosis 2016 15, 332-339DOI: (10.1016/j.jcf.2015.10.013) Copyright © 2015 European Cystic Fibrosis Society Terms and Conditions

Fig. 4 Pro-inflammatory cytokine response of CF and control BECs upon RV infection. (A) IL-6, (B) IL-8 and (C) IP-10 protein levels were assessed in CF and control BECs by ELISA at 24h post-infection. IM (infection media), pIC (poly(IC)). Significant differences between conditions (IM, RV16, RV1B, pIC) are indicated by stars above and are relative to the mock infection control (IM). Significant differences between groups (control and CF) are indicated by horizontal lines. Stars indicate significance levels, *p<0.05, **p<0.01, ****p<0.0001. Journal of Cystic Fibrosis 2016 15, 332-339DOI: (10.1016/j.jcf.2015.10.013) Copyright © 2015 European Cystic Fibrosis Society Terms and Conditions